All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| 1-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea | CHEBI_94923 | |
| N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide | CHEBI_94928 | |
| 4,4,4-trifluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide | CHEBI_111760 | |
| N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide | CHEBI_94929 | |
| N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide | CHEBI_111761 | |
| biphenyls | CHEBI_22888 | [Benzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.] |
| nordazepam | CHEBI_111762 | [A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.] |
| 1,4-benzodiazepinone | CHEBI_35500 | |
| sedative | CHEBI_35717 | [A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.] |
| anxiolytic drug | CHEBI_35474 | [Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.] |
| human metabolite | CHEBI_77746 | [Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).] |
| GABA modulator | CHEBI_50268 | [A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.] |
| anticonvulsant | CHEBI_35623 | [A drug used to prevent seizures or reduce their severity.] |
| N-demethylindolmycin | CHEBI_111763 | [A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted at the 2 and 5-pro-S positions by amino and [(1R)-1-(1H-indol-3-yl)ethyl] groups, respectively.] |
| 1,3-oxazoles | CHEBI_46812 | |
| indoles | CHEBI_24828 | [Any compound containing an indole skeleton.] |
| primary amino compound | CHEBI_50994 | [A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.] |
| N-demethylindolmycin(1+) | CHEBI_91178 | [An organic cation obtained by protonation at position 3 in the oxazole ring of N-demethylindolmycin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).] |
| 2-demethylmenaquinol | CHEBI_55437 | [A polyprenylnaphthohydroquinone that is naphthalene-1,4-diol having a polyprenyl substituent of unspecified chain-length at the 2-position.] |
| naphthohydroquinone | CHEBI_51475 | [A hydroxynaphthalene that is naphthalene-1,4-diol and its C-substituted derivatives.] |